Interesting publication from National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo using ProteoSave, low bind tubes

"Increased cerebrospinal fluid complement C5 levels in major depressive disorder and schizophrenia" published in Biochemical and Biophysical Research Communications, Volume 497, Issue 2, 4 March 2018, Pages 683-688 mentions the use of ProteoSave 15 ml low bind tubes.